At the 2018 Aptimmune Scientific Symposium, Dr. Andy Kryzer of Fairmont Veterinary Clinic in Fairmont, Minn., shared an evaluation of the Aptimmune vaccine in Porcine Reproductive and Respiratory Syndrome (PRRS) viremic piglets. Kryzer said the study trialed the vaccine at weaning only versus weaning and two weeks post weaning to see if the approaches were equally effective at reducing PRRS … Read More
Swine Vets Excited About Barricade Vaccine
Three different trials on Minnesota hog farms resulting in encouraging evidence for the success of Aptimmune‘s Barricade vaccines. Dr. Chris Sievers, associate veterinarian at the Swine Vet Center in Minnesota presented on the trials at the 2018 Aptimmune Scientific Symposium. “The exciting thing with Aptimmune is we have a vaccine that’s killed that’s showing some effectiveness,” said Sievers. “I should … Read More
Reducing Mortality with Barricade PRRS
Participants in the 2018 Aptimmune Scientific Symposium heard some real world examples of how Barricade PRRS is helping farmers to fight the illness in their herds. Dr. Natalie Baker shared evidence of the vaccine’s success after Porcine Reproductive and Respiratory Syndrome (PRRS) broke on an Indiana operation in April 2017. “We followed these pigs out and looked at mortality data … Read More
New Isolation Technique Improves Vaccine Development
Scientific breakthroughs in the way a virus can be isolated from diagnostic samples are improving the development of vaccines to fight porcine reproductive and respiratory syndrome (PRRS) virus. The success rate was not good when the virus was isolated in traditional simian (MARC-145) cells. The Iowa State University Veterinary Diagnostic Laboratory is working with Aptimmune Biologics, Inc. to use the … Read More
Outsmarting the PRRS Virus
The 2018 Aptimmune Scientific Symposium focused on the success of the Barricade vaccine for porcine reproductive and respiratory syndrome (PRRS), which was introduced in 2017. “PRRS is a daunting challenge and a difficult vaccine to not only develop but also manage in the production world,” said Dr. Bob Nordgren, chairman of the board for Aptimmune. “For 20 years, we’ve come … Read More
Aptimmune Vaccines Gaining Popularity
Aptimmune is looking to grow its presence in the swine vaccine market with the success of Barricade for porcine reproductive & respiratory syndrome (PRRS). “It’s kind of an exciting time because we launched the product over a year ago and we’ve got customers that are using the product, evaluating it in a number of trials,” said Steve Berger, director of … Read More
Aptimmune Shares Barricade Vaccine Field Data
In the year since Aptimmune launched the Barricade vaccine to fight porcine reproductive & respiratory syndrome (PRRS), the company has been gathering field data from 30 different veterinarians in 12 different states. “We’ve been able to see a 50 percent reduction in mortality across the board, so it’s been very rewarding,” said Dr. Jessica Seate, professional service veterinarian for Aptimmune. … Read More
New Swine Inactivated Mucosal Flu A Virus Vaccine from Aptimmune
Aptimmune Biologics introduces the industry’s first inactivated mucosal influenza A virus in swine (IAV-S) vaccine administered via nasal spray. Aptimmune’s IAV-S vaccine utilizes the BARRICADE™ proprietary vaccine formulation that gives swine producers and veterinarians a completely different approach to conventional inactivated injectable and live virus vaccines for safely preventing and managing respiratory disease. This inactivated mucosal vaccine is a new … Read More
Aptimmune Biologics Adds Veterinarian to Swine Team
Aptimmune Biologics announces the addition of Jessica Seate, DVM, as a veterinarian for the company’s swine division. In her new role, Seate will help launch Aptimmune’s new PRRSV and Influenza vaccines made with BARRICADE® formulation technology, as well as assist in the development of the company’s portfolio of swine vaccines. “Dr. Seate’s extensive technical experience in swine vaccine marketing and … Read More
Aptimmune Adds Sales Veterans to its Swine Team
Aptimmune announces the addition of three new strategic account managers to the company’s swine division focusing on the new Aptimmune autogenous PRRS vaccine made with BARRICADE® technology. They will also help grow the Aptimmune portfolio of swine vaccines and augment the company’s sales organization with experienced swine industry professionals. Joining Aptimmune this month are Andy Wuethrich, Brian Konz and Andy … Read More